Sign in to fuzzto save your conversations, follow your research and come back anytime.
Valiant Organics
VALIANTORG
NSE
BSE
NSEBSESectorChemicals
316.15
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Valiant Organics shows a strong operational rebound in Q1 FY27, with revenue and profits surging after a mid-year dip.
EBITDA recovered from ₹156 Cr in Q3 FY26 to ₹416 Cr in Q1 FY27, highlighting strong operational turnaround.
Market price fell from ₹414.70 in Q1 FY26 to ₹269.30 in Q1 FY27, indicating sustained investor caution.
PAT margin expanded from 2.26% in Q3 FY26 to 12.66% in Q1 FY27, reflecting better profit conversion.
Average trading volume dropped from 89.9 in Q1 FY26 to 56.32 in Q1 FY27, signaling reduced market liquidity.
EPS jumped from ₹1.30 in Q3 FY26 to ₹10.44 in Q1 FY27, driven by higher earnings and stable share count.
Total expenses rose from ₹1,435 Cr in Q3 FY26 to ₹1,899 Cr in Q1 FY27, tracking higher operational activity.
Operating revenue climbed from ₹1,593 Cr in Q3 FY26 to ₹2,315 Cr in Q1 FY27, confirming top-line momentum.
Chlorination sales volume eased from 3,487 MT in Q4 FY26 to 2,623 MT in Q1 FY27, showing seasonal demand shifts.
